tiprankstipranks
Anbio Biotechnology Class A (NNNN)
NASDAQ:NNNN
US Market
NNNN
Anbio Biotechnology Class A
RESEARCH TOOLSreports
Want to see NNNN full AI Analyst Report?

Anbio Biotechnology Class A (NNNN) Ratios

60 Followers

Anbio Biotechnology Class A Ratios

NNNN's free cash flow for Q4 2024 was $0.85. For the 2024 fiscal year, NNNN's free cash flow was decreased by $ and operating cash flow was $-0.52. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 344.31 344.31 10.71 15.86 9.88
Quick Ratio
 344.31 344.31 10.71 15.86 9.63
Cash Ratio
 88.42 88.42 6.80 9.76 5.03
Solvency Ratio
 81.82 82.28 1.37 2.28 7.10
Operating Cash Flow Ratio
 18.27 -76.72 1.20 0.90 3.15
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 30.16M$ 30.16M$ 16.80M$ 14.76M$ 12.53M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.00 1.00 1.10 1.07 1.11
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 1.25K
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 1.27K
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.00 0.00 0.00 0.00 <0.01
Net Debt to EBITDA
 -1.20 -1.19 -4.58 -4.27 -0.71
Profitability Margins
Gross Profit Margin
87.06%87.24%71.90%50.07%53.36%
EBIT Margin
66.47%66.70%28.99%33.58%42.55%
EBITDA Margin
66.47%66.70%31.36%33.77%42.58%
Operating Profit Margin
66.47%66.70%24.38%29.22%43.30%
Pretax Profit Margin
73.75%74.06%28.99%33.58%42.52%
Net Profit Margin
73.75%74.06%28.99%33.58%42.52%
Continuous Operations Profit Margin
73.75%74.06%28.99%33.58%42.52%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
110.95%111.02%118.92%114.93%98.19%
Return on Assets (ROA)
23.76%23.90%12.54%14.25%71.72%
Return on Equity (ROE)
23.00%23.97%13.80%15.21%79.79%
Return on Capital Employed (ROCE)
21.48%21.59%11.61%13.23%81.26%
Return on Invested Capital (ROIC)
21.48%21.59%11.61%13.23%81.26%
Return on Tangible Assets
23.76%23.90%12.54%14.25%71.72%
Earnings Yield
0.50%0.55%0.97%0.27%1.21%
Efficiency Ratios
Receivables Turnover
 2.66 2.67 7.69 3.56 6.57K
Payables Turnover
 0.00 0.00 1.42 4.05 7.80
Inventory Turnover
 0.00 0.00 0.00 0.00 31.03
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 1.95K
Asset Turnover
 0.32 0.32 0.43 0.42 1.69
Working Capital Turnover Ratio
 0.31 0.42 0.52 0.49 3.13
Cash Conversion Cycle
 136.97 136.78 -210.47 12.41 -34.98
Days of Sales Outstanding
 136.97 136.78 47.48 102.50 0.06
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 11.76
Days of Payables Outstanding
 0.00 0.00 257.95 90.09 46.80
Operating Cycle
 136.97 136.78 47.48 102.50 11.82
Cash Flow Ratios
Operating Cash Flow Per Share
 0.04 -0.15 0.05 <0.01 0.03
Free Cash Flow Per Share
 0.04 -0.15 0.05 <0.01 0.03
CapEx Per Share
 <0.01 0.00 0.00 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 959.54K 0.00 0.00 0.00 1.54M
Capital Expenditure Coverage Ratio
 959.54K 0.00 0.00 0.00 1.54M
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.16 -0.69 0.25 0.13 0.19
Free Cash Flow Yield
0.11%-0.51%0.85%0.11%0.54%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 198.61 182.63 102.84 368.39 82.93
Price-to-Sales (P/S) Ratio
 146.47 135.25 29.81 123.70 35.26
Price-to-Book (P/B) Ratio
 47.33 43.77 14.19 56.03 66.17
Price-to-Free Cash Flow (P/FCF) Ratio
 889.59 -195.84 117.30 924.18 186.62
Price-to-Operating Cash Flow Ratio
 889.59 -195.84 117.30 924.18 186.62
Price-to-Earnings Growth (PEG) Ratio
 1.99 0.98 0.40 -4.76 0.48
Price-to-Fair Value
 47.33 43.77 14.19 56.03 66.17
Enterprise Value Multiple
 219.16 201.56 90.49 362.00 82.11
Enterprise Value
 1.42B 1.31B 232.26M 820.56M 823.15M
EV to EBITDA
 219.16 201.56 90.49 362.00 82.11
EV to Sales
 145.67 134.45 28.38 122.25 34.96
EV to Free Cash Flow
 884.75 -194.69 111.64 913.40 185.03
EV to Operating Cash Flow
 884.75 -194.69 111.64 913.40 185.03
Tangible Book Value Per Share
 0.69 0.69 0.41 0.10 0.09
Shareholders’ Equity Per Share
 0.69 0.69 0.41 0.10 0.09
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.22 0.22 0.19 0.05 0.16
Net Income Per Share
 0.16 0.16 0.06 0.02 0.07
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.11 1.11 1.00 1.00 1.00
Research & Development to Revenue
 0.02 0.02 0.06 0.02 <0.01
SG&A to Revenue
 0.18 0.18 0.42 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -1.21 -1.05 0.88 0.40 0.44
Currency in USD